Home

ALTA BIOPHARMA PARTNERS II LP

CIK 1163156 · last filed 2008-11-13

ALTA BIOPHARMA PARTNERS II LP is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2008. The most recent filing shows the insider was granted $1.1M of CORT on Nov 13, 2008. Current disclosed insider exposure totals $599.4M across reported positions. The firm reports its address in San Francisco, CA. 23 SEC filings were submitted jointly with ALTA BIOPHARMA MANAGEMENT II LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$599.44M

Companies

1

Total Filings

1

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
ONE EMBARCADERO CENTER, SUITE 3700
SAN FRANCISCO, CA 94111
Phone
(415) 362-4022
Related Filers
ALTA BIOPHARMA MANAGEMENT II LLC — 23 joint filings, latest 2014-05-08
ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC — 23 joint filings, latest 2014-05-08
FARAH CHAMPSI — 22 joint filings, latest 2014-05-08
ALIX MARDUEL — 15 joint filings, latest 2008-11-13
JEAN DELEAGE — 6 joint filings, latest 2009-10-20
ACP IV, L.P. — same reported address
ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG — same reported address
ALTA BIOPHARMA PARTNERS III LP — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CORT 10%+ Owner 5,314,616 $112.79 $599.44M $0 1 2008-11-13

Recent Filings

1 filing
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2008-11-13 CORT Grant (A) +733,782 $1.06M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.